Invenomic Institutional holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Invenomic Fund Institutional Class shares BIVIX
- NAV / 1-Day Return 15.41 / −0.39 %
- Total Assets 817.7M
-
Adj. Expense Ratio
2.240%
- Expense Ratio 3.040%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Long-Short Equity
- Investment Style Small Value
- Min. Initial Investment 50,000
- Status Limited
- TTM Yield 2.49%
- Turnover 197%
USD | NAV as of Jun 13, 2026 | 1-Day Return as of Jun 13, 2026, 1:03 AM GMT+0
Morningstar’s Analysis BIVIX
Will BIVIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the BIVIX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of BIVIX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 12.1
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Us Dollar Broker | 73.31 | 725M | Cash and Equivalents |
Australian Dollar | 4.13 | 41M | Cash and Equivalents |
First American Government Obligs X | 3.15 | 31M | Cash and Equivalents |
Akamai Technologies Inc | 2.79 | 28M | Technology |
Eldorado Gold Corp | 2.74 | 27M | Basic Materials |
Dentsply Sirona Inc | 2.73 | 27M | Healthcare |
Sonoco Products Co | 2.69 | 27M | Consumer Cyclical |
Lyft Inc Class A | 2.69 | 27M | Technology |
Global Payments Inc | 2.45 | 24M | Industrials |
Viatris Inc | 2.21 | 22M | Healthcare |
United States